How Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market is estimated to be worth around USD 20.1 billion by 2030 ?
Question
Nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers, are either already available in the market or under development across the world
Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.
Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market, Forecast to 2030
The financial opportunity within the liquid biopsy and other non-invasive cancer diagnostics market has been analyzed across the following segments:
Type of Tumor Marker
- ctDNA
- cfDNA
- CTCs
- Exosomes
- Others
Application
- Diagnosis / Early Diagnosis
- Patient Monitoring
- Recurrence Monitoring
Target Cancer Indication
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Bladder Cancer
- Melanoma
- Gastric Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others
End Users
- Hospitals
- Research Institutes
- Others
Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Rest of the World
Get Latest Market Insights:
The Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers report features the following companies, which we identified to be key players in this domain:
Key Players:
- Amoy Diagnostics
- DiaCarta
- HaploX Biotechnology
- NeoGenomics
- QIAGEN
- Swift Biosciences
- Sysmex Inostics
- Thermo Fisher Scientific
Table of Contents
- Preface
- Executive Summary
- Introduction
- Non-Invasive Cancer Screening and Diagnosis
- Market Landscape
- Company Profiles
- Partnerships and Collaborations
- Funding and Investment Analysis
- Liquid Biopsy: Initiatives of Big Pharma Players
- Key Acquisition Targets
- Other Non-Invasive Cancer Diagnostics
- Market Sizing and Opportunity Analysis
- Survey Insights
- Conclusion
- Executive Insights
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
Request for Customization: https://www.rootsanalysis.com/reports/279/request-customization.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Also Visit Our Latest Publication:
Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market
Patient Recruitment and Retention Services Market
Leave an answer